119 related articles for article (PubMed ID: 11015698)
1. Trends in live birth prevalence of down syndrome in the Northern Netherlands 1987-96: the impact of screening and prenatal diagnosis.
Wortelboer MJ; De Wolf BT; Verschuuren-Bemelmans CC; Reefhuis J; Mantingh A; Beekhuis JR; Cornel MC
Prenat Diagn; 2000 Sep; 20(9):709-13. PubMed ID: 11015698
[TBL] [Abstract][Full Text] [Related]
2. Down syndrome: effects of demographic factors and prenatal diagnosis on the future livebirth prevalence.
Cornel MC; Breed AS; Beekhuis JR; te Meerman GJ; ten Kate LP
Hum Genet; 1993 Sep; 92(2):163-8. PubMed ID: 8370583
[TBL] [Abstract][Full Text] [Related]
3. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
Jou HJ; Kuo YS; Hsu JJ; Shyu MK; Hsieh TT; Hsieh FJ
Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of live birth Down syndrome in the region of Primorsko-goranska County in Croatia, 1996-2005: the impact of screening and amniocentesis.
Brajenović-Milić B; Prpić I; Petrović O; Ristić S; Brumini G; Kapović M
Matern Child Health J; 2008 Sep; 12(5):620-3. PubMed ID: 17712614
[TBL] [Abstract][Full Text] [Related]
5. Estimates of live birth prevalence of children with Down syndrome in the period 1991-2015 in the Netherlands.
de Graaf G; Engelen JJM; Gijsbers ACJ; Hochstenbach R; Hoffer MJV; Kooper AJA; Sikkema-Raddatz B; Srebniak MI; van der Kevie-Kersemaekers AMF; van Zutven LJCM; Voorhoeve E
J Intellect Disabil Res; 2017 May; 61(5):461-470. PubMed ID: 28261902
[TBL] [Abstract][Full Text] [Related]
6. Unchanged prevalence of Down syndrome in the Netherlands: results from an 11-year nationwide birth cohort.
van Gameren-Oosterom HB; Buitendijk SE; Bilardo CM; van der Pal-de Bruin KM; Van Wouwe JP; Mohangoo AD
Prenat Diagn; 2012 Nov; 32(11):1035-40. PubMed ID: 22865545
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the introduction of the national Down syndrome screening program in the Netherlands: age-related uptake of prenatal screening and invasive diagnostic testing.
Engels MA; Bhola SL; Twisk JW; Blankenstein MA; van Vugt JM
Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():59-63. PubMed ID: 24405726
[TBL] [Abstract][Full Text] [Related]
8. Impact of prenatal screening and diagnostic testing on trends in Down syndrome births and terminations in Western Australia 1980 to 2013.
Maxwell S; Bower C; O'Leary P
Prenat Diagn; 2015 Dec; 35(13):1324-30. PubMed ID: 26411476
[TBL] [Abstract][Full Text] [Related]
9. The effects of prenatal diagnosis, population ageing, and changing fertility rates on the live birth prevalence of Down syndrome in New York State, 1983-1992.
Olsen CL; Cross PK; Gensburg LJ; Hughes JP
Prenat Diagn; 1996 Nov; 16(11):991-1002. PubMed ID: 8953632
[TBL] [Abstract][Full Text] [Related]
10. A population-based study of prevalence of Down syndrome in Southern Thailand.
Jaruratanasirikul S; Kor-Anantakul O; Chowvichian M; Limpitikul W; Dissaneevate P; Intharasangkanawin N; Sattapanyo A; Pathompanitrat S; Sriplung H
World J Pediatr; 2017 Feb; 13(1):63-69. PubMed ID: 27878784
[TBL] [Abstract][Full Text] [Related]
11. [Prenatal diagnosis and prevalence of Down syndrome in the Parisian population, 2001-2005].
de Vigan C; Khoshnood B; Cadio E; Vodovar V; Goffinet F
Gynecol Obstet Fertil; 2008 Feb; 36(2):146-150. PubMed ID: 18249576
[TBL] [Abstract][Full Text] [Related]
12. Down syndrome: interaction between culture, demography, and biology in determining the prevalence of a genetic trait.
Olsen CL; Cross PK; Gensburg LJ
Hum Biol; 2003 Aug; 75(4):503-20. PubMed ID: 14655874
[TBL] [Abstract][Full Text] [Related]
13. [Impact of maternal age distribution on the expected live birth prevalence of Down's syndrome in the metropolitan France between 1965 and 2008].
Rousseau T; Ferdynus C; Thauvin-Robinet C; Gouyon JB; Sagot P
J Gynecol Obstet Biol Reprod (Paris); 2010 Jun; 39(4):284-9. PubMed ID: 20381272
[TBL] [Abstract][Full Text] [Related]
14. [Study on key techniques and intervention in reducing birth defects].
Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
[TBL] [Abstract][Full Text] [Related]
15. Recent trends in the birth prevalence of Down syndrome in China: impact of prenatal diagnosis and subsequent terminations.
Deng C; Yi L; Mu Y; Zhu J; Qin Y; Fan X; Wang Y; Li Q; Dai L
Prenat Diagn; 2015 Apr; 35(4):311-8. PubMed ID: 25315427
[TBL] [Abstract][Full Text] [Related]
16. The impact of antenatal screening for Down syndrome in Western Australia: 1980-1994.
O'Leary P; Bower C; Murch A; Crowhurst J; Goldblatt J
Aust N Z J Obstet Gynaecol; 1996 Nov; 36(4):385-8. PubMed ID: 9006817
[TBL] [Abstract][Full Text] [Related]
17. Changes in yearly birth prevalence rates of children with Down syndrome in the period 1986-2007 in The Netherlands.
de Graaf G; Haveman M; Hochstenbach R; Engelen J; Gerssen-Schoorl K; Poddighe P; Smeets D; van Hove G
J Intellect Disabil Res; 2011 May; 55(5):462-73. PubMed ID: 21375641
[TBL] [Abstract][Full Text] [Related]
18. Down syndrome prevention program in a population with an older maternal age.
Shohat M; Legum C; Romem Y; Borochowitz Z; Bach G; Goldman B
Obstet Gynecol; 1995 Mar; 85(3):368-73. PubMed ID: 7862374
[TBL] [Abstract][Full Text] [Related]
19. Older mothers and increased impact of prenatal screening: stable livebirth prevalence of trisomy 21 in the Netherlands for the period 2000-2013.
de Groot-van der Mooren MD; Tamminga S; Oepkes D; Weijerman ME; Cornel MC
Eur J Hum Genet; 2018 Feb; 26(2):157-165. PubMed ID: 29330546
[TBL] [Abstract][Full Text] [Related]
20. Prenatal testing for Down syndrome in the Jewish and non-Jewish populations in Israel.
Davidov B; Goldman B; Akstein E; Barkai G; Legum C; Dar H; Romem Y; Amiel A; Cohen H; Bach G
Isr J Med Sci; 1994 Aug; 30(8):629-33. PubMed ID: 8045747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
